Author:
Xie Zhouling,Oscar Benimana,Zhao Lulu,Ding Xue,Cao Chen,Feng Sen,Li Han,Pan Chen,Bian Ziyi,Li Yang,Wang Weijun,Kong Yi,Li Zhiyu
Funder
National Natural Science Foundation of China
China Pharmaceutical University
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference26 articles.
1. Progress in the research of GPIIb/IIIa antagonists, future;Xie;Med. Chem.,2015
2. Newer anti-platelet and anti-thrombotic drugs on the horizon;Garg;Nat. J. Physio. Pharm. Pharm.,2013
3. Antithrombotic effects of LB30870, a potent, orally active, selective and direct thrombin inhibitor, and pharmacokinetics of its prodrug;Park;Bioorg. Med. Chem. Lett.,2013
4. Antiplatelet therapies for the treatment of cardiovascular disease;Alan;Nat. Rev. Drug Discov.,2010
5. Use of antiplatelet agents in sepsis: a glimpse into the future;Karolina;Thromb. Res.,2014
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献